Manifestations and Related Risk Factors of Thrombocyte Abnormalities in HIV-Positive Patients Before and After the Initiation of ART

References

• George JN. Platelets. Lancet. 2000;355(9214):1531–1539. doi:10.1016/s0140-6736(00)02175-910801186
   PubMed Web of Science ®Google Scholar
• Borges AH, Lundgren JD, Ridolfo A, et al. Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease. AIDS. 2014;28(17):2565–2571. doi:10.1097/qad.000000000000043325574959
   PubMed Web of Science ®Google Scholar
• Shen Y, Wang J, Wang Z, et al. A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS. Biosci Trends. 2015;9(2):91–96. doi:10.5582/bst.2015.0102426173294
   PubMed Web of Science ®Google Scholar
• Fan H-W, Guo F-P, Li Y-J, et al. Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients. Chin Med J. 2015;128(4):459–464. doi:10.4103/0366-6999.15107825673446
   PubMed Web of Science ®Google Scholar
• Ambler KLS, Vickars LM, Leger CS, et al. Clinical features, treatment, and outcome of HIV-associated immune thrombocytopenia in the HAART era. Adv Hematol. 2012;2012:910954. doi:10.1155/2012/91095422693513
   PubMedGoogle Scholar
• Bello JL, Burgaleta C, Magallon M, et al. Hematological abnormalities in hemophilic patients with human immunodeficiency virus infection. Am J Hematol. 1990;33(4):230–233. doi:10.1002/ajh.28303304032316506
   PubMed Web of Science ®Google Scholar
• Erhabor O, Ejele OA, Nwauche CA, et al. Some haematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med. 2005;14(1):33–38. doi:10.4314/njm.v14i1.3713215832640
   PubMedGoogle Scholar
• Kyeyune R, Saathoff E, Ezeamama AE, et al. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infect Dis. 2014;14:496. doi:10.1186/1471-2334-14-49625209550
   PubMed Web of Science ®Google Scholar
• Fan L, Li C, Zhao H. Prevalence and risk factors of cytopenia in HIV-infected patients before and after the initiation of HAART. Biomed Res Int. 2020;2020:3132589. doi:10.1155/2020/313258932090076
   PubMed Web of Science ®Google Scholar
• Nka AD, Sosso SM, Fokam J, et al. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé. BMC Res Notes. 2019;12(1):632. doi:10.1186/s13104-019-4664-731554515
   PubMed Web of Science ®Google Scholar
• Lai SW, Huang CY, Lai HC, et al. Thrombocytopenia and its related factors: a hospital-based, cross-sectional study. Ann Acad Med Singapore. 2010;39(1):9–12.20126807
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang W, Li F, et al. Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV-related liver disease. Liver Int. 2014;34(4):535–543. doi:10.1111/liv.1230924612171
   PubMed Web of Science ®Google Scholar
• Rios R, Sangro B, Herrero I, et al. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol. 2005;100(6):1311–1316. doi:10.1111/j.1572-0241.2005.41543.x15929762
   PubMed Web of Science ®Google Scholar
• Choi SY, Kim I, Kim NJ, et al. Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol. 2011;46(4):253–257. doi:10.5045/kjh.2011.46.4.25322259631
   PubMedGoogle Scholar
• Deressa T, Damtie D, Workineh M, et al. Anemia and thrombocytopenia in the cohort of HIV-infected adults in northwest Ethiopia: a facility-based cross-sectional study. EJIFCC. 2018;29(1):36–47.29765285
   PubMedGoogle Scholar
• Woldeamanuel GG, Wondimu DH. Prevalence of thrombocytopenia before and after initiation of HAART among HIV infected patients at black lion specialized hospital, Addis Ababa, Ethiopia: a cross sectional study. BMC Hematol. 2018;18:9. doi:10.1186/s12878-018-0103-629760930
   PubMedGoogle Scholar
• Cretton EM, Xie MY, Bevan RJ, et al. Catabolism of 3ʹ-azido-3ʹ-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3ʹ-amino-3ʹ-deoxythymidine, a highly toxic catabolite for human bone marrow cells. Mol Pharmacol. 1991;39(2):258–266.1996084
   PubMed Web of Science ®Google Scholar
• Schafer AI. Thrombocytosis. JAMA. 2015;314(11):1171–1172. doi:10.1001/jama.2015.851526372588
   PubMed Web of Science ®Google Scholar
• McMullin MF. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis. Hematol Am Soc Hematol Edu Program. 2019;2019(1):391–396. doi:10.1182/hematology.2019000047
   Google Scholar
• Rose SR, Petersen NJ, Gardner TJ, et al. Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res. 2012;4(6):415–423. doi:10.4021/jocmr1125w23226175
   PubMedGoogle Scholar
• Ellaurie M. Thrombocytosis in pediatric HIV infection. Clin Pediatr. 2004;43(7):627–629. doi:10.1177/000992280404300707
   Web of Science ®Google Scholar
• Schafer AI. Thrombocytosis. N Engl J Med. 2004;350(12):1211–1219. doi:10.1056/NEJMra03536315028825
   PubMed Web of Science ®Google Scholar
• Gauldie J, Richards C, Harnish D, et al. Interferon B2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute-phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987;84(20):7251–7255. doi:10.1073/pnas.84.20.72512444978
   PubMed Web of Science ®Google Scholar
• Bilic E, Bilic E. Amino acid sequence homology of throm-bopoietin and erythropoietin may explain thrombocytosis in children with iron deficiency anemia. J Pediatr Hematol Oncol. 2003;25(8):675–676. doi:10.1097/00043426-200308000-0002312902931
   PubMed Web of Science ®Google Scholar
• Dubé MP, Sprecher D, Henry WK, et al. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin Infect Dis. 2000;31(5):1216–1224. doi:10.1086/31742911073755
   PubMed Web of Science ®Google Scholar
• Savona S, Nardi MA, Lennette ET, et al. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med. 1985;102(6):737–741. doi:10.7326/0003-4819-102-6-7372986504
   PubMed Web of Science ®Google Scholar
• Raffetti E, Donato F, Casari S, et al. Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study. BMC Infect Dis. 2017;17(1):193. doi:10.1186/s12879-017-2280-528264665
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Oya R, Kitamiura T, et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis. Head Neck. 2018;40(3):647–655. doi:10.1002/hed.2498629076207
   PubMed Web of Science ®Google Scholar
• Taylor KA, Smyth E, Rauzi F, et al. Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk. Br J Pharmacol. 2019;176(7):879–889. doi:10.1111/bph.1458930681136
   PubMed Web of Science ®Google Scholar
• Loelius SG, Lannan KL, Blumberg N, et al. The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro. Thromb Res. 2018;169:96–104. doi:10.1016/j.thromres.2018.07.00330031293
   PubMed Web of Science ®Google Scholar
• Laurence J, Elhadad S, Gostynska S, et al. HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways. AIDS. 2020;34(7):989–1000. doi:10.1097/qad.000000000000251632167970
   PubMed Web of Science ®Google Scholar
• Dai G, Xiao J, Gao G, et al. Anemia in combined antiretroviral treatment-naive HIV-infected patients in China: a retrospective study of prevalence, risk factors, and mortality. Biosci Trends. 2017;10(6):445–453. doi:10.5582/bst.2016.0116527890886
   PubMed Web of Science ®Google Scholar
• Evstatiev R, Bukaty A, Jimenez K, et al. Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin. Am J Hematol. 2014;89(5):524–529. doi:10.1002/ajh.2368224464533
   PubMed Web of Science ®Google Scholar
• Mesquita EC, Hottz ED, Amancio RT, et al. Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals. Sci Rep. 2018;8(1):14999. doi:10.1038/s41598-018-33403-030301959
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Jacobs, Jr DR, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201(12):1788–1795. doi:10.1086/65274920446848
   PubMed Web of Science ®Google Scholar
• Gleissner CA, Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arteriosclerosis, thrombosis, and vascular biology. Arteriosclerosis, Thrombosis, Vasc Biol. 2008;28(11):1920–1927. doi:10.1161/atvbaha.108.169417
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2013.
   Google Scholar
• O’Brien MP, Zafar MU, Rodriguez JC, et al. Targeting thrombogenicity and inflammation in chronic HIV infection. Sci Adv. 2019;5(6):eaav5463. doi:10.1126/sciadv.aav546331206016
   PubMed Web of Science ®Google Scholar
• O’Brien M, Montenont E, Hu L, et al. Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr. 2013;63(3):280–288. doi:10.1097/QAI.0b013e31828a292c23406976
   PubMed Web of Science ®Google Scholar